Ligand validation:1G2N

EPH: L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE

EPH is a Ligand Of Interest in 1G2N designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1G2N_EPH_A_4000	24%	37%	0.185	0.813	1.38	1.09	6	2	9	0	100%	1
1R20_EPH_A_4000	29%	19%	0.218	0.875	1.84	1.61	13	6	7	0	100%	1
7BJV_EPH_A_501	21%	46%	0.297	0.91	0.94	1.13	2	4	9	0	100%	1
2R40_EPH_A_600	17%	38%	0.27	0.853	1.32	1.13	5	2	3	0	100%	1
7BJU_EPH_A_501	12%	48%	0.335	0.873	0.92	1.07	2	3	5	0	100%	1
3IXP_EPH_A_900	7%	13%	0.365	0.82	1.83	2.15	13	4	1	0	100%	1
4ONI_EPH_A_601	63%	46%	0.144	0.939	1.01	1.08	2	3	4	0	100%	1
5Z9O_EPH_B_402	61%	42%	0.167	0.965	1.05	1.2	3	4	9	0	96%	1
4PLE_EPH_G_601	51%	80%	0.161	0.924	0.28	0.55	-	-	0	0	96%	1
4DOR_EPH_B_601	49%	46%	0.158	0.912	0.98	1.12	2	5	9	0	96%	1
4YSX_EPH_D_201	34%	41%	0.182	0.886	1.13	1.18	2	4	2	0	90%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.